📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors. (2020)

First Author: Wanigasooriya K

Attributed to: Integrating innovative technologies for genotyping and phenotyping in stratified medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers12051278

PubMed Identifier: 32443649

Publication URI: http://europepmc.org/abstract/MED/32443649

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancers

Issue: 5

ISSN: 2072-6694